Biology | Free Full-Text | ApoA-I-Mediated Lipoprotein Remodeling Monitored with a Fluorescent Phospholipid
The association of apolipoproteins with later-life all-cause and cardiovascular mortality: a population-based study stratified by age | Scientific Reports
apoA-V Antibody (A-12) | SCBT - Santa Cruz Biotechnology
Heterozygosity for apolipoprotein A-I(R160L)Oslo is associated with low levels of high density lipoprotein cholesterol and HDL-s
Apo(a) and ApoB Interact Noncovalently Within Hepatocytes: Implications for Regulation of Lp(a) Levels by Modulation of ApoB Secretion | Arteriosclerosis, Thrombosis, and Vascular Biology
![Anti CD25 / IL2RA (Activated Lymphocyte Marker) Mab [IL2RA/2395] - Antibody Research Corporation](https://cdn11.bigcommerce.com/s-e7c5fvpp1c/images/stencil/500x659/products/264034/260807/monoclonal__71134.1675353318.png?c=2 "Anti CD25 / IL2RA (Activated Lymphocyte Marker) Mab [IL2RA/2395] - Antibody Research Corporation")
Anti CD25 / IL2RA (Activated Lymphocyte Marker) Mab [IL2RA/2395] - Antibody Research Corporation
Abstract 15086: Associations Between Apolipoprotein A-I Proteoforms and Markers of Cardiometabolic Health | Circulation
Plasma levels of apolipoproteins C-III, A-IV, and E are independently associated with stable atherosclerotic cardiovascular disease - ScienceDirect
Biomedicines | Free Full-Text | Current Understanding of the Immunomodulatory Activities of High-Density Lipoproteins
An apoA-I mimetic peptide facilitates off-loading cholesterol from HDL to liver cells through scavenger receptor BI
The apoB/apoA-I Ratio is a Strong Predictor of Cardiovascular Risk | IntechOpen
The Central Helices of ApoA-I Can Promote ATP-binding Cassette Transporter A1 (ABCA1)-mediated Lipid Efflux - Journal of Biological Chemistry
IVD Antibody Development Services for ApoA, B, E Markers - Creative Biolabs
HDL cholesterol efflux normalised to apoA-I is associated with future development of type 2 diabetes: from the CORDIOPREV trial | Scientific Reports
HDL-apoA-I Exchange: Rapid Detection and Association with Atherosclerosis | PLOS ONE
Initial interaction of apoA-I with ABCA1 impacts in vivo metabolic fate of nascent HDL - ScienceDirect
IVD Antibody Development Services for Apolipoprotein A1 Marker - Creative Biolabs
Apolipoprotein A-I-containing lipoproteins with pre-beta electrophoretic mobility.
Paired Measurements of Paraoxonase 1 and Serum Amyloid A as Useful Disease Markers
Apolipo proteins
Subfractional distribution of Apo B-containing lipoproteins: a new marker for detection of individual cardiovascular risk
The apoB/apoA‐I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid‐lowering therapy – a review of the evidence - WALLDIUS - 2006 - Journal of Internal Medicine -
Scientists identify marker that predicts changes in cholesterol levels as people grow older. - Healthinnovations- Latest Innovative Health & Medical News
Effect of apoA-I PEGylation on the Biological Fate of Biomimetic High-Density Lipoproteins | ACS Omega
Characterization of the apolipoprotein A-I (apoA-I). (A) The protein... | Download Scientific Diagram
The Apolipoprotein B/Apolipoprotein A-I Ratio as a Potential Marker of Plasma Atherogenicity
